Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

@article{Armstrong2010ProphylaxisOC,
  title={Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.},
  author={Edward P. Armstrong},
  journal={Journal of managed care pharmacy : JMCP},
  year={2010},
  volume={16 3},
  pages={
          217-30
        }
}
  • Edward P. Armstrong
  • Published 2010
  • Medicine
  • Journal of managed care pharmacy : JMCP
  • BACKGROUND Vaccines have demonstrated cost-effectiveness in managed care through the prevention of disease. As new vaccines for previously untargeted conditions are developed, pharmacoeconomic modeling is becoming even more critical for the quantification of value in the health care industry. Two recently developed vaccines aimed at prevention of infection from human papillomavirus (HPV) types 16 and 18 have proven to be highly efficacious. HPV 16 and 18 are the 2 most common oncogenic strains… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 139 CITATIONS, ESTIMATED 68% COVERAGE

    Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Human Papillomavirus Infection and Vaccination.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2009
    2020

    CITATION STATISTICS

    • 10 Highly Influenced Citations

    • Averaged 7 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 67 REFERENCES

    Cost Effectiveness of a Potential Vaccine for Human papillomavirus

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    Health and economic implications of HPV vaccination in the United States.

    VIEW 2 EXCERPTS
    HIGHLY INFLUENTIAL

    Age-based programs for vaccination against HPV.

    A Multi-Type HPV Transmission Model